HCPCS Code Detail Logo

HCPCS Codes Similar to Q4142

HCPCS Codes Similar to “Q4142” Code.
Xcm biologic tissue matrix, per square centimeter (add-on, list separately in addition to primary procedure)

C9770
Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent
Code added date: 20210101
Code effective date: 20240101
G2182
Patient receiving first-time biologic and/or immune response modifier therapy
Code added date: 20210101
Code effective date: 20230101
G9359
Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier
Code added date: 20140101
Code effective date: 20230101
G9506
Biologic immune response modifier prescribed
Code added date: 20160101
Code effective date: 20230101
G9652
Patient has been treated with a systemic or biologic medication for psoriasis for at least six months
Code added date: 20160101
Code effective date: 20170101
G9653
Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months
Code added date: 20160101
Code effective date: 20170101
M1003
Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy
Code added date: 20190101
Code effective date: 20230101
C1734
Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)
Code added date: 20200101
Code effective date: 20230101
C9354
Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter
Code added date: 20080101
Code effective date: 20080101
G0682
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute for a wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
Code added date: 20260401
Code effective date: 20260401
G0684
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
Code added date: 20260401
Code effective date: 20260401
G0681
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute for a wound surface area up to 100 sq cm; first 25 sq cm or less of wound surface area
Code added date: 20260401
Code effective date: 20260401
G0683
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
Code added date: 20260401
Code effective date: 20260401
C9784
Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components
Code added date: 20230701
Code effective date: 20260101